Site-specific pegylation of G-CSF by reversible denaturation

被引:70
作者
Veronese, Francesco M.
Mero, Anna
Caboi, Francesca
Sergi, Mauro
Marongiu, Christian
Pasut, Gianfranco
机构
[1] Univ Padua, Dept Pharmaceut Sci, I-35100 Padua, Italy
[2] Bioker Srl, I-09010 Pula, CA, Italy
关键词
D O I
10.1021/bc070123+
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new strategy has been developed for extending the possibility of poly(ethylene glycol) (PEG) modification to accessible thiol groups of biologically active proteins. In particular, thiol-reactive PEGs have been coupled to the cysteine 17 of granulocyte colony stimulating factor (G-CSF), which is known to be partially buried in a hydrophobic protein pocket. The PEG linking was accomplished by partial protein denaturation with 3 M guanidine center dot HCl in the absence of any reducing agent in order to preserve the native protein's disulfide bridges. PEG coupling occurred also, but at a lower degree, by using a 3 M solution of urea as the denaturing agent. Following the PEGylation, which was carried out in the unfolded state, the conjugated protein was refolded using dialysis or gel filtration chromatography to eliminate the denaturant. Different thiol-reactive PEGs and polymer molecular weights (5, 10, or 20 kDa) were investigated for G-CSF conjugation under denaturation. The secondary structure of the protein in the G-CSF-PEG conjugates, evaluated using circular dichroism and biological activity assay in cell culture, was maintained with respect to the native protein. Unexpectedly, conjugation enhanced the G-CSF tendency to aggregate, a problem that was overcome by a proper formulation.
引用
收藏
页码:1824 / 1830
页数:7
相关论文
共 24 条
[1]   Granulocyte colony-stimulating factor receptor: Structure and function [J].
Akbarzadeh, S ;
Layton, JE .
VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 63, 2001, 63 :159-194
[2]   CYSTEINE-17 OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IS PARTIALLY SOLVENT-EXPOSED [J].
ARAKAWA, T ;
PRESTRELSKI, SJ ;
NARHI, LO ;
BOONE, TC ;
KENNEY, WC .
JOURNAL OF PROTEIN CHEMISTRY, 1993, 12 (05) :525-531
[3]  
BERNA M, 2005, 32 INT S CONTR REL N
[4]   PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER [J].
BRONCHUD, MH ;
SCARFFE, JH ;
THATCHER, N ;
CROWTHER, D ;
SOUZA, LM ;
ALTON, NK ;
TESTA, NG ;
DEXTER, TM .
BRITISH JOURNAL OF CANCER, 1987, 56 (06) :809-813
[5]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[6]   PEGylation of growth hormone-releasing hormone (GRF) analogues [J].
Esposito, P ;
Barbero, L ;
Caccia, P ;
Caliceti, P ;
D'Antonio, M ;
Piquet, G ;
Veronese, FM .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (10) :1279-1291
[7]  
FIBBE WE, 1989, EXP HEMATOL, V17, P229
[8]   COMPUTED CIRCULAR DICHROISM SPECTRA FOR EVALUATION OF PROTEIN CONFORMATION [J].
GREENFIE.N ;
FASMAN, GD .
BIOCHEMISTRY, 1969, 8 (10) :4108-&
[9]   Effects of site-specific polyethylene glycol modification of recombinant human granulocyte colony-stimulating factor on its biologic activities [J].
Hao, Yong ;
Chen, Junhui ;
Wang, Xinchang ;
Zhu, Haowen ;
Rong, Zhigang .
BIODRUGS, 2006, 20 (06) :357-362
[10]  
Herman A C, 1996, Pharm Biotechnol, V9, P303